Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04281472
Brief Title: A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves) (ADHERE)

First Submitted : February 20, 2020
First Submitted that Met QC Criteria : February 21, 2020
First Posted : February 24, 2020

Last Update Submitted that Met QC Criteria : November 25, 2021
Last Update Posted : November 29, 2021